Westfield Capital Management
MNTA

Westfield Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Westfield Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-409,804
Closed -$13.6M – 263
2020
Q2 		$13.6M Buy
409,804
+92,401
+29% +$2.94M 0.09% 187
2020
Q1 		$8.63M Sell
317,403
-386,250
-55% -$10.8M 0.08% 181
2019
Q4 		$13.9M Sell
703,653
-279,563
-28% -$4.47M 0.1% 177
2019
Q3 		$12.7M Sell
983,216
-268,563
-21% -$3.24M 0.1% 179
2019
Q2 		$15.6M Buy
1,251,779
+44,815
+4% +$595K 0.12% 184
2019
Q1 		$17.5M Buy
1,206,964
+569,604
+89% +$7.28M 0.13% 181
2018
Q4 		$7.04M Buy
+637,360
New +$8.87M 0.06% 201

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Westfield Capital Management's MNTA Position: Q3 2020 in Review

Westfield Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 409,804 shares — an estimated $13.6M sold.

Westfield Capital Management first reported a position in MNTA in Q4 2018 and held it in 7 quarters. The position peaked at $17.5M in Q1 2019. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Westfield Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Westfield Capital Management sold 409,804 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $13.6M.
  • Westfield Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2018 and held it in 7 quarters.
  • Westfield Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $17.5M in Q1 2019.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Westfield Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.